- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Niemann-Pick sykdom, type B
Total 3929 results
-
Weill Medical College of Cornell UniversityEpizyme, Inc.; Genentech, Inc.RecruitingLymphoma, Non-Hodgkin | Follicular Lymphoma | Diffuse Large B Cell LymphomaUnited States
-
The First Affiliated Hospital of Soochow UniversityRecruitingNon-GCB/ABC Diffuse Large B-Cell LymphomaChina
-
Debiopharm International SACompletedDiffuse Large B-Cell Lymphoma | B-cell Non-Hodgkin's LymphomaUnited States, Czechia, Bulgaria, Belgium, Hungary, Ukraine, Italy, Poland, Switzerland
-
BeBetter Med IncActive, not recruitingRelapsed or Refractory Diffuse Large B-cell LymphomaChina
-
University Hospital Southampton NHS Foundation...CompletedNon Hodgkin LymphomaUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterM.D. Anderson Cancer Center; National Cancer Institute (NCI); University of California... and other collaboratorsActive, not recruitingHodgkin's Lymphoma | Diffuse Large B-cell LymphomaUnited States
-
University Medical Center GroningenHoffmann-La Roche; Amsterdam UMC, location VUmc; Stichting Hemato-Oncologie voor...WithdrawnDiffuse Large B-Cell Lymphoma, Not Otherwise SpecifiedNetherlands
-
ImmunityBio, Inc.WithdrawnLymphoma | Lymphoma, B-Cell | Diffuse Large B Cell Lymphoma | Large-cell LymphomaUnited States
-
International Extranodal Lymphoma Study Group (IELSG)CompletedMarginal Zone B-cell LymphomaItaly, France
-
George Washington UniversityWithdrawnNon-Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | DLBCLUnited States
-
Royal Marsden NHS Foundation TrustMerck Sharp & Dohme LLC; Mundipharma-EDO GmbHWithdrawnRelapsed or Refractory Diffuse Large B-cell LymphomaUnited Kingdom
-
Zhengzhou UniversityCompletedDiffuse Large B Cell Lymphoma | Relapsed and RefractoryChina
-
International Extranodal Lymphoma Study Group (IELSG)TerminatedDiffuse Large B-Cell Lymphoma of the Breast
-
Korea Cancer Center HospitalUnknownRelapsed or Refractory Marginal Zone B-cell LymphomaKorea, Republic of
-
National Cancer Institute (NCI)Active, not recruitingPlasmablastic Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Recurrent High Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements | Refractory High Grade B-Cell... and other conditionsUnited States
-
Sociedad de Lucha Contra el Cáncer del EcuadorNot yet recruitingNeoplasms | Lymphoma, B-Cell | Cancer | Non Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | High-grade B-cell Lymphoma | MetabolomicsEcuador
-
Fondazione Italiana Linfomi - ETSRoche Pharma AGWithdrawnDiffuse Large B-cell Lymphoma Recurrent | Diffuse Large B Cell Lymphoma RefractoryItaly
-
Zhujiang HospitalShenzhen Geno-Immune Medical InstituteWithdrawnInterleukin-2 Following 4SCAR19/22 T Cells Targeting Refractory and/or Recurrent B Cell MalignanciesB-Cell Leukemia | B-Cell LymphomaChina
-
Memorial Sloan Kettering Cancer CenterActive, not recruitingB-Cell Lymphoma | B-cell Non Hodgkin Lymphoma | B Cell ALLUnited States
-
Masonic Cancer Center, University of MinnesotaActive, not recruitingNon Hodgkin Lymphoma | Diffuse Large B Cell Lymphoma | NHL | High-grade B-cell LymphomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell LymphomaUnited States
-
Novartis PharmaceuticalsWithdrawnDiffuse Large B-Cell Lymphoma (DLBCL)
-
Northwestern UniversityNational Cancer Institute (NCI); Gateway for Cancer ResearchTerminatedStage III Diffuse Large B-Cell Lymphoma | Stage IV Diffuse Large B-Cell LymphomaUnited States
-
Academic and Community Cancer Research UnitedNot yet recruitingPrimary Mediastinal Large B-Cell Lymphoma | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Transformed Indolent B-Cell Non-Hodgkin Lymphoma to Diffuse Large B-Cell LymphomaUnited States
-
Ruijin HospitalNot yet recruitingRelapsed or Refractory B-cell LymphomaChina
-
Hoffmann-La RocheRecruiting
-
PfizerHoffmann-La RocheRecruitingDiffuse Large B-Cell LymphomaUnited States, Taiwan, Japan, Israel
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.RecruitingDiffuse Large B-Cell LymphomaChina
-
GenmabAbbVieRecruitingDiffuse Large B-Cell LymphomaFrance, Korea, Republic of, Spain, Belgium, Japan, Germany, Czechia, United Kingdom, Italy, Austria, United States, Poland
-
GenmabAbbVieRecruitingDiffuse Large B-Cell LymphomaKorea, Republic of, Spain, Japan, Israel, Australia, Poland, Netherlands, Sweden, Greece, Taiwan, Italy, Denmark, Switzerland, France, Bulgaria, Hungary, Austria, New Zealand, Czechia, Croatia, Belgium, Brazil, China, United States, Canada and more
-
The First Affiliated Hospital of Soochow UniversityRecruitingDiffuse Large B-Cell LymphomaChina
-
Sun Yat-sen UniversityNot yet recruiting
-
M.D. Anderson Cancer CenterRecruiting
-
Peking Union Medical College HospitalRecruitingIntravascular Large B-Cell LymphomaChina
-
University of RochesterRecruiting
-
Hoffmann-La RocheCompletedLymphoma, Large B-Cell, DiffuseUnited States, France, Spain, Italy
-
Mabion SACompletedDiffuse Large B-Cell LymphomaSerbia, Poland, Croatia, Bosnia and Herzegovina, Georgia, Moldova, Republic of, Ukraine
-
Patrick ReaganSeagen Inc.Active, not recruitingDiffuse Large B-Cell LymphomaUnited States
-
Incyte CorporationCompleted
-
Herlev HospitalCompletedLymphoma, Large B-Cell, DiffuseDenmark
-
M.D. Anderson Cancer CenterGenentech, Inc.; CelgeneCompleted
-
ADC Therapeutics S.A.WithdrawnDiffuse Large B-Cell LymphomaUnited States
-
Incyte CorporationCompletedLymphomaUnited States, Spain, Korea, Republic of, Belgium, Australia, Czechia, Poland, Canada, France, Italy, United Kingdom
-
University Hospital, MontpellierCompleted
-
University of BirminghamAstraZeneca; Cancer Research UK; BloodwiseCompletedDiffuse Large B-Cell LymphomaUnited Kingdom
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)Completed
-
Genentech, Inc.Completed
-
Hoffmann-La RocheCompleted
-
Gruppo Italiano Terapie Innovative nei LinfomiCompletedDiffuse Large B-Cell LymphomaItaly